• Quest Diagnostics disclosed results from a Nature Communications study on multidrug-resistant Klebsiella pneumoniae spreading in US communities.
• Researchers found common UTI-linked strains often resisted standard oral treatments, raising the risk of treatment failure in routine outpatient care.
• The findings point to rising demand for advanced testing, surveillance, and new therapies, with some patients potentially needing injectable antibiotics.
• The study was based on more than 2,000 deidentified resistant isolates collected across 42 states, skewing toward older patients and women.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quest Diagnostics Incorporated published the original content used to generate this news brief via PR Newswire (Ref. ID: 202606180857PR_NEWS_USPR_____NY86563) on June 18, 2026, and is solely responsible for the information contained therein.